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tract infections in adults: an observational
case–control study in primary care in
Belgium
Johan Flamaing1,2*, Wilfried De Backer3, Yves Van Laethem4, Stéphane Heijmans5 and Annick Mignon6Due to a change in reagent affecting the performance of
the Urinary Antigen Detection (UAD) assay, the positivity
cut-off values of the assay had to be revised. A number of
epidemiological studies have been affected by this change,
including the original version of this article [1].
All samples of the study have been reanalysed and the
impact on the study results can be found in the attached
Excel sheet (Additional file 1):
 Due to change in cut-off for serotype 5 and 14, there
is one case of serotype 5 and of serotype 14 less.
 The revision of the analysis showed 1 additional
positive results for serotype 18C and for serotype 23 F
 Overall the total number of positive UAD results
has not changed.
Results of the assay are shown in the corrected Tables 3
and 4, included in this erratum.Additional file
Additional file 1: Changes in UAD results. (XLSX 12 kb)
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Table 3 Cross-table of the results of the BinaxNOW and Urine Antigen Detection assaysa
BinaxNOW assay Total N(%)
Negative N(%) Positive N(%)
Urine Antigen Detection Assay Negative N (%) 433 (95.0) 8 (1.7) 441 (96.7)
Positive N (%) 11 (2.4) 4 (0.9) 15 (3.3)
Total N (%) 444 (97.4) 12 (2.6) 456 (100.0)
a88 contaminated samples were eliminated from the analysis
Table 4 Number and proportion of the serotypes in
pneumococcal serious lower respiratory tract infections using
the Urine Antigen Detection (UAD) assay








23 F 1 6.67
Totala 15 100.0
a15 (3.3 %) out of 456 SLRTI cases were positive for the UAD assay
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